Trial Profile
A study to investigate safety and efficacy of Telaprevir in combination with peginterferon and ribavirin in patients with chronic hepatitis C
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Peginterferon; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 07 Dec 2015 New trial record